Lalan S. Wilfong, MD, on Metastatic Solid Tumors: Limiting Low-Value Care
2018 ASCO Quality Care SymposiumLalan S. Wilfong, MD, of Texas Oncology, discusses reducing the use of a white blood cell growth factor treatment in advanced and incurable solid tumors for patients treated at a community oncology practice.
Related Videos
Jay B. Shah, MD, on Reducing Opioid Use After Urologic Oncology Surgery
Jay B. Shah, MD, of Stanford University, discusses the role that surgeons can play as gatekeepers to the opioid epidemic, including the view that complex cancer operations can be p...
Simron Singh, MD, MPH, on Patient-Centered Care: Measuring Experience
Simron Singh, MD, MPH, of Sunnybrook Health Sciences Centre, discusses initial results of his data on a new patient experience measurement strategy used at Cancer Care Ontario.
Neeraj K. Arora, PhD, on Patient-Centered Care in Clinical Practice
Neeraj K. Arora, PhD, of the Patient Centered Outcomes Research Institute (PCORI), discusses his work at PCORI and the central role that patients play in improving care and outcome...
Jeremy Warner, MD, on Patient Navigation: Weathering the Storm of Cancer Care
Jeremy Warner, MD, of Vanderbilt-Ingram Cancer Center, discusses the ways in which patient navigators affect cancer care and how patients benefit.
Aaron Lyss, MBA, on Getting the Highest-Value Quality Intervention
Aaron Lyss, MBA, of Tennessee Oncology, discusses ways that clinicians and patients can employ the most cost- and treatment-effective measures, clinical trials, and incident learni...
